Background Image
Previous Page  182 / 188 Next Page
Information
Show Menu
Previous Page 182 / 188 Next Page
Page Background

Version 2.2015, 03/11/15 © National Comprehensive Cancer Network, Inc. 2015, All rights reserved.

The NCCN Guidelines® and this illustration may not be reproduced in any form without the express written permission of NCCN®.

MS-107

NCCN Guidelines Index

Breast Cancer Table of Contents

Discussion

NCCN Guidelines Version 2.2015

Breast Cancer

2006;47:1202-1208. Available at:

http://www.ncbi.nlm.nih.gov/pubmed/16818956

.

548. Germann N, Goffinet F, Goldwasser F. Anthracyclines during

pregnancy: embryo-fetal outcome in 160 patients. Ann Oncol

2004;15:146-150. Available at:

http://www.ncbi.nlm.nih.gov/pubmed/14679135

.

549. Johnson PH, Gwyn K, Gordon N, et al. The treatment of pregnant

women with breast cancer and the outcomes of the children exposed to

chemotherapy in utero [abstract]. J Clin Oncol 2005;23(Suppl

16):Abstract 540. Available at:

http://meeting.ascopubs.org/cgi/content/abstract/23/16_suppl/540

.

550. Doll DC, Ringenberg QS, Yarbro JW. Antineoplastic agents and

pregnancy. Semin Oncol 1989;16:337-346. Available at:

http://www.ncbi.nlm.nih.gov/pubmed/2678485 .

551. Ebert U, Loffler H, Kirch W. Cytotoxic therapy and pregnancy.

Pharmacol Ther 1997;74:207-220. Available at:

http://www.ncbi.nlm.nih.gov/pubmed/9336023 .

552. Hahn KME, Johnson PH, Gordon N, et al. Treatment of pregnant

breast cancer patients and outcomes of children exposed to

chemotherapy in utero. Cancer 2006;107:1219-1226. Available at:

http://www.ncbi.nlm.nih.gov/pubmed/16894524

.

553. Gainford MC, Clemons M. Breast cancer in pregnancy: are

taxanes safe? Clinical Oncol (R Coll Radiol) 2006;18:159. Available at:

http://www.ncbi.nlm.nih.gov/pubmed/16523825

.

554. Garcia-Manero M, Royo MP, Espinos J, et al. Pregnancy

associated breast cancer. Eur J Surg Oncol 2009;35:215-218. Available

at:

http://www.ncbi.nlm.nih.gov/pubmed/18550321 .

555. Gonzalez-Angulo AM, Walters RS, Carpenter RJ, et al. Paclitaxel

chemotherapy in a pregnant patient with bilateral breast cancer. Clin

Breast Cancer 2004;5:317-319. Available at:

http://www.ncbi.nlm.nih.gov/pubmed/15507181

.

556. Mir O, Berveiller P, Ropert S, et al. Emerging therapeutic options

for breast cancer chemotherapy during pregnancy. Ann Oncol

2008;19:607-613. Available at:

http://www.ncbi.nlm.nih.gov/pubmed/17921242

.

557. Bader AA, Schlembach D, Tamussino KF, et al. Anhydramnios

associated with administration of trastuzumab and paclitaxel for

metastatic breast cancer during pregnancy. Lancet Oncol 2007;8:79-81.

Available at:

http://www.ncbi.nlm.nih.gov/pubmed/17196514

.

558. Fanale MA, Uyei AR, Theriault RL, et al. Treatment of metastatic

breast cancer with trastuzumab and vinorelbine during pregnancy. Clin

Breast Cancer 2005;6:354-356. Available at:

http://www.ncbi.nlm.nih.gov/pubmed/16277887

.

559. Pant S, Landon MB, Blumenfeld M, et al. Treatment of breast

cancer with trastuzumab during pregnancy. J Clin Oncol 2008;26:1567-

1569. Available at:

http://www.ncbi.nlm.nih.gov/pubmed/18349415

.

560. Sekar R, Stone PR. Trastuzumab use for metastatic breast cancer

in pregnancy. Obstet Gynecol 2007;110:507-510. Available at:

http://www.ncbi.nlm.nih.gov/pubmed/17666645

.

561. Shrim A, Garcia-Bournissen F, Maxwell C, et al. Favorable

pregnancy outcome following Trastuzumab (Herceptin) use during

pregnancy--Case report and updated literature review. Reprod Toxicol

2007;23:611-613. Available at:

http://www.ncbi.nlm.nih.gov/pubmed/17399946

.

562. Waterston AM, Graham J. Effect of Adjuvant Trastuzumab on

Pregnancy. J Clin Oncol 2006;24:321-322. Available at:

http://www.ncbi.nlm.nih.gov/pubmed/16401684

.

563. Watson WJ. Herceptin (trastuzumab) therapy during pregnancy:

association with reversible anhydramnios. Obstet Gynecol